Tolerability and Pharmacokinetics of CSPCHA115 Capsules in Chinese Healthy Volunteers
Condition: Asthma; Allergic Rhinitis Interventions: Drug: CSPCHA115 100 mg; Matching placebo 100 mg; Drug: CSPCHA115 200 mg; Matching placebo 200 mg; Drug: CSPCHA115 400 mg; Matching placebo 400 mg; Drug: CSPCHA115 600 mg; Matching placebo 600 mg Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials